Scopio on the future of telehematology
Through full-field digital cell morphology, Scopio Labs’ technology can automate the analysis of tens of…
January 26, 2023 - 4 minutes
Interview
Watch: Queen’s University tackling antimicrobial resistance
One of the biggest global challenges facing healthcare systems is bacteria and viruses becoming resistant…
January 24, 2023 - 2 minutes
Watch: pHion Therapeutics talks about next-generation mRNA vaccines
pHion Therapeutics is a U.K.-based vaccine development company. It is developing a pipeline of therapeutic…
January 23, 2023 - 1 minute
Interview: Proscia talks about digital pathology
Labiotech recently interviewed Nathan Buchbinder, chief product officer at Proscia, about digital pathology. AI has…
January 19, 2023 - 8 minutes
Sibylla Biotech: how physicists met biologists to discover new drugs
Discovering new drugs remains an inefficient, trial and error-based process. The founding team behind the…
December 14, 2022 - 9 minutes
Interview: why the recently approved fecal microbiome product is causing a rumble
The news last week of the FDA approving Ferring Pharmaceuticals' first fecal microbiome product, Rebyota,…
December 5, 2022 - 5 minutes
LAG-3: The next big checkpoint inhibitor target
Since their first approval a decade ago, immune checkpoint inhibitors have been gaining momentum in…
November 29, 2022 - 7 minutes
Breaking barriers to gene therapies for childhood rare diseases
The majority of known rare genetic diseases affect children, and gene therapies could help them…
November 28, 2022 - 5 minutes
What recent mixed clinical results can teach about Alzheimer’s disease
2022 has provided mixed fortunes for companies aiming to slow Alzheimer’s disease. Ulrich Dauer, CEO…
November 23, 2022 - 7 minutes
How cardioids can usher in the next generation of drug discovery
The California-based Molecular Devices brings automated 3D cell culture and image analysis together with HeartBeat.bio’s…
November 18, 2022 - 6 minutes
MaaT Pharma: leading the charge in microbiome therapeutics
The first generation of microbiome therapeutics is hitting its first approvals. Savita Bernal, chief business…
November 14, 2022 - 5 minutes
In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus
AstraZeneca and Sanofi’s Beyfortus (nirsevimab) has been approved in the European Union (EU) for the…
November 14, 2022 - 9 minutes
